Studies involving disease:COVID-19
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Human | University of California, Los Angeles |
| ST001735 | The COVIDome Explorer Researcher Portal (Red Blood Cells) | Human | University of Colorado Anschutz Medical Campus |
| ST001736 | The COVIDome Explorer Researcher Portal (blood plasma) | Human | University of Colorado Anschutz Medical Campus |
| ST001849 | Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (part I) | Human | Washington University in St. Louis |
| ST001853 | Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity (Part 2) | Hamster | Washington University in St. Louis |
| ST001921 | An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 Infection | Human | Weill Cornell Medicine |
| ST001933 | Absolute quantification of plasma cytokines and metabolome reveals the glycylproline regulating antibody-fading in convalescent COVID-19 patients | Human | Hong Kong Baptist University |
| ST001993 | CE-MS based metabolomics to study plasma samples that reveal new pathways implicated in SARS-CoV-2 pathogenesis | Human | Universidad CEU San Pablo |
| ST002016 | Metabolomics of COVID patients | Human | University of Virginia |
| ST002086 | Serum NMR profiling reveals differential alterations in the lipoproteome induced by Pfizer-BioNTech vaccine in COVID-19–recovered subjects and naïve subjects | Human | University of Florence |
| ST002087 | Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients | Human | University of Florence |
| ST002194 | Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation | Human | CEMBIO |
| ST002291 | Integrated metabolic and inflammatory signatures associated with severity, fatality, and recovery of COVID-19 | Human | Federal University of Goiás |
| ST002301 | Serum metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients | Human | Sharjah Institute for Medical Research |
| ST002404 | Profiling Metabolites and Lipoproteins in COMETA, an Italian Cohort of COVID-19 patients-part 2 | Human | University of Florence |
| ST002476 | High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Mouse) | Mouse | Keio University |
| ST002477 | Neutrophil metabolomics in COVID-19 | Human | UT Southwestern Medical Center |
| ST002479 | High body temperature increases gut microbiota-dependent host resistance to influenza A virus and SARS-CoV-2 infection (Hamster) | Mouse | Keio University |
| ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | National Institutes of Health |
| ST002845 | Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patients | Human | Federal University of Goiás |
| ST002984 | Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19 | Human | Graduate School of Medicine, Kyoto University |
| ST003039 | A Non-Targeted Metabolomics Comparative Study on Plasma of Pfizer and Sinopharm COVID- 19 Vaccinated individuals, Assessed by (TIMS-QTOF) Mass Spectrometry. | Human | Sharjah Institute for Medical Research |
| ST003103 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Human | Universidad CEU San Pablo |
| ST003388 | RMC-113 (dual-lipid kinase inhibitor, PIKfyve, PIP4K2C) alters the phosphoinositide regioisomer signature by advanced lipidomics analysis | Human | Stanford University |
